Global COVID-19 Pandemic: Prevention and Protection Techniques

Mohajan, Haradhan (2021): Global COVID-19 Pandemic: Prevention and Protection Techniques. Published in: Journal of Economic Development, Environment and People , Vol. 10, No. 1 (31 March 2021): pp. 52-72.

Abstract

The COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). It has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. It has a high human to human transmission capability and primarily targets the human respiratory system. Healthcare providers to common people are in high risks of the contamination of this fatal disease. It spreads person to person through respiratory droplets that produced during talking, coughing and sneezing. It is associated with severe and fatal respiratory disease in humans. At present it becomes great global public health concern. On 11 March 2020, the WHO declared the global COVID-19 outbreak as a pandemic. The COVID-19 pandemic has entered in a very dangerous phase in April and May 2020, and the severity is increasing day by day. On 26 July 2020, about 216 countries and territories are infected worldwide; total global infections become more than 16.3 million and total recovered about 9.9 million with total deaths 648,477. The disease have not abolished even in the 2021. On 27 March 2021, the disease spread up to 219 countries and territories globally; total confirmed deaths become 2,783,591, total confirmed cases 127,025,229, with total recovery 102,370,710. The paper discusses the social, economic, and health impacts in the world's poorest countries due to COVID-19 pandemic outbreak. The study also presents the current economic situation of the world and analyses the potential consequences on global economy. An attempt has been taken here to create consciousness among the common people to reduce the fatality of this killer disease. From the beginning of 2021, COVID-19 vaccines are distributed worldwide and all nations are united to abolish the virus completely.

• Item Type: MPRA Paper
• Language: English
• Keywords: COVID-19, SARS-CoV-2, SARS-CoV, MERS-CoV, Wuhan, pandemic, vaccines, variants
• Subjects: I - Health, Education, and Welfare > I1 - Health; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health > I15 - Health and Economic Development

References

Al-Osail, A. M., & Al-Wazzah, M. J. (2017). The History and Epidemiology of Middle East Respiratory Syndrome Coronavirus. Multidisciplinary Respiratory Medicine, 12(20), 1–6.

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., & Al-Hajjar, A. et al. (2013). Epidemiological, Demographic, and Clinical Characteristics of 47 Cases of Middle East Respiratory Syndrome Coronavirus Disease from Saudi Arabia: A Descriptive Study. The Lancet Infectious Diseases, 13, 752–761.

Azhar, E. I., Hui, D. S. C., Memish, Z. A., Drosten, C., & Zumla, A. (2019). The Middle East Respiratory Syndrome (MERS). Infectious Disease Clinics of North America, 33(4), 891–905.

Baldwin, R., & di Mauro, B. W. (Eds.) (2020). Economics in the Time of COVID-19. Centre for Economic Policy Research (CEPR) Press, London.

Beaumont, P. (2020). Covid-19 Vaccine: Who are Countries Prioritising for First Doses? The Guardian.

Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020). The 2019-New Coronavirus Epidemic: Evidence for Virus Evolution. bioRxiv January 2020.

Barrero, J. M., Bloom, N., & Davis, S. J. (2020). COVID-19 is Also a Reallocation Shock. Working Paper No. 2020-59, Becker Friedman Institute.

BioFire (2020). The BioFireFilmArray Respiratory EZ (RP EZ) Panel. https://www.biofiredx.com/products/the-filmarray-panels/filmarray-respiratory-panel-ez/

Callaway, E. (2020). Coronavirus: Labs Worldwide Scramble to Analyse Samples. Nature, 578, 16.

Carlos, W. G., Cruz, C. S., Cao, B., Pasnick, S., & Jamil, S. (2020). Novel Wuhan (2019-nCoV) Coronavirus. American Journal of Respiratory and Critical Care Medicine, 201(4), 7–8. https://doi.org/10.1164/rccm.2014P7

CDC (2003). Update: Outbreak of Severe Acute Respiratory Syndrome–Worldwide, 2003. MMWR Morb Mortal Weekly Report, 52(12), 241–246.

CDC (2019). MERS Transmission. US Centers for Disease Control and Prevention. US Department of Health & Human Services.

CDC (2020). Prevention and Treatment. US Centre for Disease Control and Prevention. US Department of Health & Human Services.

CDC (2021a). Information about the Pfizer-BioNTech COVID-19 Vaccine. Centre for Disease Control and Prevention (CDC), US Department of Health & Human Services.

CDC (2021b). Emerging SARS-CoV-2 Variants. Centre for Disease Control and Prevention (CDC), US Department of Health & Human Services.

Center for Health Security (2020a). Fact Sheet: Coronaviruses: SARS, MERS, and 2019-nCoV. Johns Hopkins Bloomberg School of Public Health.

Center for Health Security (2020b). Diagnostic Testing for 2019-nCoV. Johns Hopkins Bloomberg School of Public Health.

Center for Health Security (2020c). Serology Testing for COVID-19. Johns Hopkins Bloomberg School of Public Health.

Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., & Yang, J. et al. (2020). A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster. Lancet, 395, 514–523. https://doi.org/10.1016/S0140-6736(20)30154-9

Chang, L., Yan, Y., & Wang, L. (2020). Coronavirus Disease 2019: Coronaviruses and Blood Safety. Transfusion Medical Reviews. Preprint. https://doi.org/10.1016/j.tmrv.2020.02.003

Channel 24 (2020). Channel 24. A Private TV Channel of Bangladesh.

Chen, J. (2020). Pathogenicity and Transmissibility of 2019-nCoV: A Quick Overview and Comparison with Other Emerging Viruses. Microbes and Infection, 22, 69–72.

Chen, Z., Zhang, W., Lu, Y., & Guo, C. et al. (2020). From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends. https://doi.org/10.1101/2020.01.24.919241

Cho, H., Excler, J. L., Kim, J. H., & Yoon, I. K. (2018). Development of Middle East Respiratory Syndrome Coronavirus Vaccines-Advances and Challenges. Human Vaccines & Immunotherapeutics, 14(2), 304–313.

Cleri, D. J., Ricketti, A. J., & Vernaleo, J. R. (2010). Severe Acute Respiratory Syndrome (SARS). Infectious Disease Clinics of North America, 24(1), 175–202.

Corum, J., & Zimmer, C. (2021). How Nine Covid-19 Vaccines Work. The New York Times.

COVID-19 (2021). COVID-19 Vaccine Development Pipeline. Vaccine Centre, London School of Hygiene and Tropical Medicine.

Crossley, B. M., Mock, R. E., Callison, S. A., & Hietala, S. K. (2012). Identification and Characterization of a Novel Alpaca Respiratory Coronavirus Most Closely Related to the Human Coronavirus 229E. Viruses, 4(12), 3689–3700.

de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., & Fouchier, R. A. M., et al. (2013). Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87(14), 790–7792.

de Haan, C. A., de Wit, M., Kuo, L., Montalto-Morrison, C., Haagmans, B. L., & Weiss, S. R., et al. (2003). The Glycosylation Status of the Murine Hepatitis Coronavirus M Protein Affects the Interferogenic Capacity of the Virus in Vitro and Its Ability to Replicate in the Liver but Not the Brain. Virology, 312, 395–406.

ECDC (2020). Outbreak of Sever Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Increased Transmission beyond China- Fourth Update. European Centre for Disease Prevention and Control (ECDC).

ECDC (2020). Rapid Increase of a SARS-CoV-2 Variant with Multiple Spike Protein Mutations Observed in the United Kingdom. European Centre for Disease Prevention and Control (ECDC), Stockholm, UK.

Enserink, M. (2020). Update: ‘A Bit Chaoitic’. Christening of New Coronavirus and Its Disease Name Create Confusion. American Association for the Advancement of Science, Science Magazine.

Feng, J., Li, Q., Zhang, Y., Wu, Z., Dong, X., & Ma, H. et al. (2020). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)–China, 2020. Chinese Center for Disease Control and Prevention, 2(8), 113–122.

Geller, C., Varbanov, M., & Duval, R. E. (2012). Human Coronaviruses: Insights into Environmental Resistance and its Influence on the Development of New Antiseptic Strategies. Viruses, 4(11), 3044–3068.

Graham, R. L., & Baric, R. S. (2010). Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission. Journal of Virology, 84, 3134–3146.

Gralinski, L., & Menachery, V. (2020). Return of the Coronavirus: 2019-nCoV, Viruses, 12(2), 135.

Guarner, J. (2020). Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19. American Journal of Clinical Pathology, 153, 420–421.

Haider, M., Khan, S., Rabbani, M. R., & Thalassinos, Y. E. (2020). An Artificial Intelligence and NLP Based Islamic Fin Tech Model Combining Zakat and Qardh-Al-Hasan for Countering the Adverse Impact of COVID 19 on SMEs and Individuals. International Journal of Economics and Business Administration, VIII(2), 351–364.

Heymann, D. L., Mackenzie, J. S., & Peiris, M. (2013). SARS Legacy: Outbreak Reporting is Expected and Respected. Lancet, 381(9869), 779–781.

Heymann, D. L., & Shindo, N. (2020). COVID-19: What is Next for Public Health? Lancet, 395, 542–545. https://doi.org/10.1016/S0140-6736(20)30374-3

Holm, P., & Moritsugu, K. (2020). Where the Virus has Spread. Associated Press.

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., & Bruce, H. et al. (2020). First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine, 382(10), 929–936.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., & Hu, Y. et al. (2020). Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

Hui, D. S., Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., & Dar, O. et al. (2020). The Continuing 2019-nCoV Epidemic Threat of Novel Coronaviruses to Global Health: The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264–266.

Hui, D. S. C., & Zumla, A. (2019). Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infectious Disease Clinics of North America, 33(4), 869–889.

ILO (2020). COVID-19 and the World of Work: Impact and Policy Responses. International Labour Organization (ILO) Monitor 1st Edition, 18 March 2020, Genève.

Jean, S.-S., Lee, P.-I., & Hsueh, P.-R. (2020). Treatment Options for COVID-19: The Reality and Challenges, Journal of Microbiology, Immunology and Infection. Article in Press. https://doi.org/10.1016/j.jmii.2020.03.034

Josephs, L. (2020). American Airlines Cutting International Summer Schedule by 60% as Coronavirus Drives Down Demand. CNBC News, 2 April. https://www.cnbc.com/2020/04/02/coronavirus-update-american-airlines-cuts-summer-internationalflights-by-60percent-as-demand-suffers.html

Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of Coronaviruses on Inanimate Surfaces and its Inactivation with Biocidal Agents. Journal of Hospital Infection, 104(3), 246–251.

Khailany, R. A., Safdar, M., & Ozaslan, M. (2020). Genomic Characterization of a Novel SARS-CoV-2. Gene Reports. https://doi.org/10.1016/j.genrep.2020.100682

Kim, Y., Kim, S.-G., & Kim, S. - M. et al. (2020). Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell Host & Microbe, 27, 1–6. https://doi.org/10.1016/j.chom.2020.03.023

Kramer, A. E. (2020). Russia is Slow to Administer Virus Vaccine Despite Kremlin’s Approval. The New York Times.

Lam, T. T. et al. (2020) Identifying SARS-CoV-2 Related Coronaviruses in Malayan pangolins. Nature. https://doi.org/10.1038/s41586-020-2169-0

Legesse, B. (2014). Research Methods in Agribusiness and Value Chains. School of Agricultural Economics and Agribusiness, Haramaya University.

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005). Structure of SARS Coronovirus Spike Receptor-Binding Domain Complexed with Receptor. Science, 309(5742), 1864–1868.

Li, F. (2013). Receptor Recognition and Cross-Species Infections of SARS Coronavirus. Antiviral Research, 100(1), 246–254.

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., & Tong, Y. et al., (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine, 1–8. https://doi.org/10.1056/NEJMoa2001316

Li, Y. D., Chi, W. Y., Su, J. H., Ferrall, L., Hung, C. F., & Wu, T. C. (2020). Coronavirus Vaccine Development: From SARS and MERS to COVID-19. Journal of Biomedical Science, 27(1): 104.

Livingston, E, & Bucher, K. (2020). Coronavirus Disease 2019 (COVID-19) in Italy. Journal of the American Medical Association (JAMA), Preprint. https://doi:10.1001/jama.2020.4344

Lo, C.-Y., Tsai, T.-L., Lin, C.-N., Lin, C.-H., & Wu, H.-Y. (2019). Interaction of Coronavirus Nucleocapsid Protein with the 5'- and 3'- Ends of the Coronavirus Genome is Involved in Genome Circularization and Negative-Strand RNA Synthesis. FEBS Journal, 286(16), 3222–3239.

Lu, H., Stratton, C. W., & Tang, Y. W. (2020). Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle. Journal of Medical Virology, 92(4), 401–402. https://doi.org/10.1002/jmv.25678

Mascio, D., Khalil, A., & Saccone, G. et al. (2020). Outcome of Coronavirus Spectrum Infections (SARS, MERS, COVID -19) during Pregnancy: A Systematic Review and Meta-Analysis. American Journal of Obstetrics & Gynecology MFM, Pre-Print. https://doi.org/10.1016/j.ajogmf.2020.100107

Masters, P. S. (2019). Coronavirus Genomic RNA Packaging. Virology, 537, 198–207.

McNeil, S. (2020). Overview of Vaccine Efficacy and Vaccine Effectiveness. Canadian Center for Vaccinology. https://www.who.int/infl uenza_ vaccines_plan/resources/Session4_VEffi cacy_VEff ectiveness.PDF

Moderna (2021). Moderna COVID-19 vaccine-cX-024414 Injection, Suspension. DailyMed. Moderna US, Inc.

Moore, S. E., & Okyere, E. (2020). Controlling the Transmission Dynamics of COVID-19. arXiv:2004.00443v2[q-bio.PE] 2 Apr 2020.

Mohajan, H. K. (2017). Two Criteria for Good Measurements in Research: Validity and Reliability. Annals of Spiru Haret University Economic Series, 17(3), 58–82.

Mohajan, H. K. (2018). Qualitative Research Methodology in Social Sciences and Theoretical Economics. Journal of Economic Development, Environment and People, 7(1), 23–48.

Mohajan, H. K. (2020a). Most Fatal Pandemic COVID-19 Outbreak: An Analysis of Economic Consequences. Annals of Spiru Haret University Economic Series, 20(2), 127–146.

Mohajan, H. K. (2020b). COVID-19 in Italy: Remedies to Reduce the Infections and Deaths. Malaysian Journal of Medical and Biological Research, 7(2), 56–66.

Mueller, B. (2020). UK Approves Pfizer Coronavirus Vaccine, a First in the West. The New York Times.

Oxfam (2020). Coronavirus Impact: COVID-19 may Push Half Million People into Poverty, Oxfam. https://www.oxfam.org/en/oxfams-response-covid-19.

Pambuccian, S. E. (2020). The COVID-19 Pandemic: Implications for the Cytology Laboratory. Journal of the American Society of Cytopathology, Article in Press, 1–10.

Pan, X., Chen, D., Xia, Y., Wu, X., Li, T., Ou, X., Zhou, L., & Liu, J. (2020). Asymptomatic Cases in a Family Cluster with SARS-CoV-2 Infection. The Lancet Infectious Diseases, 1–2.

Pandey, P., & Pandey, M. M. (2015). Research Methodology: Tools and Techniques. Bridge Center, Romania, European Union.

Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus Infections-More than Just the Common Cold. Journal of the American Medical Association (JAMA), 323(8), 707–708.

Peiris, J. S. M., Chu, C. M., Cheng, V. C. C., Chan, K. S., & Hung, I. F. N. et al. (2003). Clinical Progression and Viral Load in a Community Outbreak of Coronavirus-Associated SARS Pneumonia: A Prospective Study. Lancet, 1–6. http://image.thelancet.com/extras/03art4432web.pdf

Pratt, E. (2021). Who Can and Can’t Safely Get the COVID-19 Vaccine. Healthline.

Punch, K. F. (2013). Introduction to Social Research: Quantitative and qualitative Approaches. SAGE Publications.

Raamsman, M. J. B., Locker, J. K., de Hooge, A., de Vries, A. A., Griffiths, G., & Vennema, H., et al. (2000). Characterization of the Coronavirus Mouse Hepatitis Virus Strain A59 Small Membrane Protein E. Journal of Virology, 74, 2333–2342.

Ramelli, S., & Wagner, A. (2020). Feverish Stock Price Reactions to COVID-19. SSRN Working Paper.

Read, J. M., Bridgen, J. R., Cummings, D. A., Ho, A., & Jewell, C.P. (2020). Novel Coronavirus 2019-nCoV: Early Estimation of Epidemiological Parameters and Epidemic Predictions. medRxiv 2020. https://doi.org/10.1101/2020.01.23.20018549

Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., & Xu, T. et al. (2020). Identification of a Novel Coronavirus Causing Severe Pneumonia in Human: A Descriptive Study. Chinese Medical Journal, 1–10. https://doi.org/10.1097/CM9.0000000000000722

Roberts, M. (2021). South Africa Coronavirus Variant: What is the Risk? BBC News. 29 January 2021.

Robertson, D. (2020). nCoV’s Relationship to Bat Coronaviruses & Recombination Signals (No Snakes). Virological, Preprint. http://virological.org/t/ncovs-relationship-to-bat-coronaviruses-recombination-signals-no-snakes/331

Rothan, H. A., & Byrareddy, S. N. (2020). The Epidemiology and Pathogenesis of Coronavirus Dieses (COVID-19) Outbreak. Journal of Autoimmunity, Preprint. https://doi.org/10.1016/j.jaut.2020.102433

Sahin, A. R., Erdogan, A., Agaoglu, P. M., Dineri, Y., Cakirci, A. Y., & Senel, M. E., et al. (2020). 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. European Journal of Medicine and Oncology, 4(1), 1–7.

Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 Infection: Origin, Transmission, and Characteristics of Human Coronaviruses. Journal of Advanced Research, 24, 91–98.

Shen, M., Peng, Z., Xiao, Y., & Zhang, L. (2020). Modelling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China. bioRxiv. https://doi.org/10.1101/2020.01.23.916726

Shrotri, M., Swinnen, T., Kampmann, B., & Parker, E. P. K. (2021). An Interactive Website Tracking COVID-19 Vaccine Development. Lancet Global Health. https://doi.org/10.1016/S2214-109X(21)00043-7

So A. D., & Woo, J. (2020). Reserving Coronavirus Disease 2019 Vaccine for Global Access: Cross Sectional Analysis, BMJ. 371: m4750.

Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019). From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses, 11, 59. https://doi.org/10.3390/v11010059

Tang, B., Wang, X., Li, Q., Bragazzi, N. L., Tang, S., & Xiao, Y. et al. (2020). Estimation of the Transmission Risk of 2019-nCov and Its Implication for Public Health Interventions. Journal of Clinical Medicine, 9(2), 462.

The Prothom Alo (2020). Coronavirus, Global Situation. The Prothom Alo 20 March 2020. A Daily News Paper of Bangladesh.

Thermofisher (2020). Solutions for Surveillance of the S Gene Mutation in the B.1.1.7 (501Y.V1) SARS-CoV-2 Strain Lineage. Thermofisher Scientific.

Thielen, P. (2020). How Mutations in the Coronavirus may Affect Development of a Vaccine. Johns Hopkins Applied Physics Laboratory. https://www.npr.org/2020/06/25/883557549/how-mutations-in-the-coronavirus-mayaffect-development-of-the-vaccine

Thomas, K., LaFraniere, S., Weiland, N., Goodnough, A., & Haberman, M. (2020). F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will be Shipped Right Away. The New York Times, 12 December 2020.

Tok, T. T., & Tatar, G. (2017). Structures and Functions of Coronavirus Proteins: Molecular Modeling of Viral Nucleoprotein. International Journal of Virology & Infectious Diseases, 2(1), 1–7.

UK (2020). Coronavirus Public Information Campaign Launched Across the UK. Government of the United Kingdom.

Vellingiri, B., Jayaramayya, K., Iyer, M., & Narayanasamy, A. (2020). COVID-19: A Promising Cure for the Global Panic. Science of the Total Environment, 725, 138277. https://doi.org/10.1016/j.scitotenv.2020.138277

Wadman, M, & Cohen, J. (2021). Novavax Vaccine Delivers 89% Efficiency against COVID-19 in UK-but is Less Potent in South Africa. Science.

Wang, C., Hornby, P. W., Hayden, F. G., & Gao, G. F. (2020a). A Novel Coronavirus Outbreak of Global Health Concern. Lancet, 395(10223), 470–473. http://dx.doi.org/10.1016/S0140-6736(20)30185-9

Wang, W., Tang, J., & Wei, F. (2020b). Updated Understanding of the Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, 92(4), 441–447. https://doi.org/10.1002/jmv.25689

WHO (2003). Coronavirus Never before Seen in Humans is the Cause of SARS–Update. Geneva: The World Health Organization.

WHO (2020a). Novel Coronavirus–China. Geneva, Switzerland: World Health Organization.

WHO (2020b). Laboratory Testing of Human Suspected Cases of Novel Coronavirus (nCoV) Infection. Interim Guidance, World Health Organization.

WHO (2020c). Pneumonia of Unknown Cause–China. World Health Organization (WHO). https://www.who.int/csr/don/05‐january‐2020‐pneumonia‐of‐unkown‐cause‐china/en/

WHO (2020d). WHO Director-General’s Remarks at the Mission Briefing on COVID-19-26 February. World Health Organization (WHO).

WHO (2020e). Advices for Public. World Health Organization (WHO).

WHO (2020f). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020.

WHO (2020g). WHO Characterizes COVID-19 as a Pandemic. World Health Organization (WHO).

WHO (2020h). Statement on the Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). World Health Organization (WHO).

WHO (2020i). Emergencies Preparedness, Response. Pneumonia of Unknown Origin–China. Disease Outbreak News. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

WHO (2021). COVAX: Working for Global Equitable Access to COVID-19 vaccines. World Health Organization (WHO).

Woo, P. C., Huang, Y., Lau, S. K., & Yuen, K. Y. (2010). Coronavirus Genomics and Bioinformatics Analysis. Viruses, 2, 1804–1820.

Worldometer (2020). COVID-19 Coronavirus Pandemic.

Worldometer (2021). COVID-19 Coronavirus Pandemic.

Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020). High Expression of ACE2 Receptor of 2019-nCoV on the Epithelial Cells of Oral Mucosa. International Journal of Oral Science, 12(1), 8.

Yang, Y., Du, L., Liu, C., Wang, L., Ma, C., Tang, J., Baric, R. S., Jiang, S., & Li, F. (2014). Receptor Usage and Cell Entry of Bat Coronavirus HKU4 Provide Insight into Bat-to-Human Transmission of MERS Coronavirus. PNAS, 111(34), 12516–12521.

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. M. (2012). Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820.

Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020). Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target. Intensive Care Medicine. Springer Science and Business Media, Preprint.

Zhang, Y., Yu, Y. S., Tang, Z. H., Chen, X. H., & Zang, G. Q. (2013). 10th Anniversary of SARS: China is Better Prepared for the H7N9 Avian Influenza Outbreak. Journal of Infection in Developing Countries, 7(10), 761–762.

Zhao, S., Lin, Q., Ran, J., Musa, S. S., Yang, G., & Wang, W. et al. (2020). Preliminary Estimation of the Basic Reproduction Number of Novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A Data-Driven Analysis in the Early Phase of the Outbreak, International Journal of Infectious Diseases, 92, 214–217. https://doi.org/10.1016/j.ijid.2020.01.050

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., George, F., & Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733.

Ziebuhr, J. (2005). The Coronavirus Replicase. Current Topics in Microbiology and Immunology, 287, 57–94.

Zimmer, C. (2021). New California Variant May Be Driving Virus Surge There, Study Suggests. Los Angeles. The New York Times.

Zumla, A., Hui, D. S., & Perlman, S. (2015). Middle East Respiratory Syndrome. Lancet, 386(9997), 995–1007.